Compound research
How is Melanotan I related to afamelanotide research?
Melanotan I is a linear alpha-MSH analog associated with the afamelanotide research lineage. Clinical publications establish that lineage but do not verify or authorize use of Astral research material.
Source trail
Selected references
Clinical commentary
An α-MSH analog in erythropoietic protoporphyria.
Luger TA, Böhm M. Journal of Investigative Dermatology (2015).
Provides clinical research context for an alpha-MSH analog without making a claim about Astral material.
Investigational-drug review
Afamelanotide, an agonistic analog of α-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria.
Minder EI. Expert Opinion on Investigational Drugs (2010).
Describes afamelanotide's research lineage and melanocortin mechanism.
How to interpret this page
These sources establish research context only. They do not verify an Astral lot, support dosing or human use, or prove safety or efficacy. Use the lot-specific COA for analytical evidence.
Editorially curated and source-verified; not independently peer-reviewed by Astral. Last source check: 2026-07-21. Read the editorial policy.